These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2323550)

  • 1. Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis.
    Gould-Kostka JL; Burns DL; Brennan MJ; Manclark CR
    FEMS Microbiol Lett; 1990 Feb; 55(3):285-9. PubMed ID: 2323550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation of A purified immunogenic pertactin from B. pertussis.
    El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF
    Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and preliminary characterization of agglutinogen 3 from Bordetella pertussis.
    Fredriksen JH; Frøholm LO; Paulsen BS
    Dev Biol Stand; 1985; 61():187-96. PubMed ID: 2872104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction.
    Skelton SK; Wong KH
    J Clin Microbiol; 1990 May; 28(5):1062-5. PubMed ID: 2351723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.
    Arciniega JL; Hewlett EL; Johnson FD; Deforest A; Wassilak SG; Onorato IM; Manclark CR; Burns DL
    J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis.
    Brennan MJ; Li ZM; Shahin RD; Burns DL; Nguyen NY; Liu TY; Gray MC; Hewlett EL; Manclark CR
    Tokai J Exp Clin Med; 1988; 13 Suppl():211-5. PubMed ID: 2908522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The property of filamentous hemagglutinin of Bordetella pertussis].
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):331-8. PubMed ID: 1845342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of Bordetella pertussis antigens using monoclonal antibodies.
    Larsen FS; Selmer JC; Hertz JB
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):271-7. PubMed ID: 6097091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bordetella pertussis acellular vaccine candidate: antigenic characterization and antibody induction.
    Dias WO; Horton DS; Takahashi CM; Raw I
    Braz J Med Biol Res; 1994 Nov; 27(11):2607-11. PubMed ID: 7549983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis.
    Li Z; Zhang Y; Wang Q; Li Z; Liu Y; Zhang S; Zhang G; Ma G; Luo J; Su Z
    Vaccine; 2016 Jul; 34(34):4032-9. PubMed ID: 27302339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-sepharose affinity chromatography.
    Chong P; Klein M
    Biochem Cell Biol; 1989 Jul; 67(7):387-91. PubMed ID: 2477043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface antigens of Bordetella pertussis.
    Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
    Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and purification of Bordetella pertussis toxin.
    Ju CL; Sheu GC; Cheng Y; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):72-83. PubMed ID: 10592813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine.
    Robbel L; Hungerer KD; Aktories K
    Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261
    [No Abstract]   [Full Text] [Related]  

  • 16. A semi-synthetic glycoconjugate antigen prepared by chemical glycosilation of pertussis toxin by a meningococcal group C oligosaccharide hapten.
    Porro M; Costantino P; Fabbiani S; Pellegrini V; Viti S
    Dev Biol Stand; 1985; 61():525-30. PubMed ID: 2423402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.
    Brennan MJ; Li ZM; Cowell JL; Bisher ME; Steven AC; Novotny P; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3189-95. PubMed ID: 2903126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reproducibility of Fim2 and Fim3 antigens determination in Bordetella pertussis by serotyping method].
    Zawadka M; Moskala B; Letowska I; Mosiej E; Krysztopa-Grzybowska K; Lutyńska A
    Med Dosw Mikrobiol; 2013; 65(3):171-9. PubMed ID: 24432556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of pertussis toxin.
    Perera VY
    Methods Enzymol; 1988; 165():120-6. PubMed ID: 2906727
    [No Abstract]   [Full Text] [Related]  

  • 20. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].
    Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.